Cascadian Therapeutics (CASC)

0.97 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/8/18 *Est.)
- M&A (3/31/18 *Est)

Latest Headlines

BioClin Therapeutics Announces New Leadership to Advance Late-Stage Bladder Cancer Development Program September 19, 2018 4:27 PM - BizWire BioClin Therapeutics Announces New Leadership to Advance Late-Stage Bladder Cancer Development Program September 18, 2018 4:06 PM - BizWire Full Article List